Invention Grant
- Patent Title: Methods and compositions for treatment of epileptic disorders
-
Application No.: US17843028Application Date: 2022-06-17
-
Publication No.: US12109201B2Publication Date: 2024-10-08
- Inventor: Matthew During
- Applicant: Ovid Therapeutics, Inc.
- Applicant Address: US NY New York
- Assignee: Ovid Therapeutics Inc.
- Current Assignee: Ovid Therapeutics Inc.
- Current Assignee Address: US NY New York
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K31/437
- IPC: A61K31/437 ; A61K9/00 ; A61K31/165 ; A61K31/19 ; A61K31/195 ; A61K31/197 ; A61K31/27 ; A61K31/325 ; A61K31/36 ; A61K31/4015 ; A61K31/4166 ; A61K31/4192 ; A61K31/423 ; A61K31/433 ; A61K31/44 ; A61K31/444 ; A61K31/4535 ; A61K31/513 ; A61K31/515 ; A61K31/53 ; A61K31/55 ; A61K31/5513 ; A61K31/5517 ; A61K31/57 ; A61K31/7048 ; A61K45/06

Abstract:
Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof.
Public/Granted literature
- US20220323424A1 METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS Public/Granted day:2022-10-13
Information query
IPC分类: